Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Z Gastroenterol ; 50(8): 771-5, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22895906

RESUMEN

We present the case of a 23-year-old female patient with acute liver failure following intake of minocycline. This patient had severe hypereosinophilia and massively increased IgE levels. Experimental studies in this case revealed elevated IFN-γ-, as well as TNF-α-producing CD4+ and CD8+ T-cells after in vitro stimulation with minocycline, indicating a type I/IgE-mediated as well as type II/cytotoxic reaction in the pathogenesis of minocycline-induced liver failure. Although mild forms of liver involvement are well known side effects of minocycline, only 8 cases with acute liver failure have been reported, and we present a review of all cases.


Asunto(s)
Fallo Hepático Agudo/inducido químicamente , Fallo Hepático Agudo/prevención & control , Minociclina/efectos adversos , Antibacterianos/efectos adversos , Diagnóstico Diferencial , Femenino , Humanos , Fallo Hepático Agudo/diagnóstico , Adulto Joven
2.
Hautarzt ; 59(11): 917-21, 2008 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-18368377

RESUMEN

For some time now, there have been reports of acral necrosis as a paraneoplasia that may occur in association with a number of different malignant tumours. There have also been a series of reports about acral necrosis associated with chemotherapy with various cytostatics. The treatment of choice if these lesions occur is plasmapheresis. Ultimately, the occurrence of thrombotic microangiopathy (TMA) can only be prevented by close monitoring through regular laboratory controls before each new cycle of chemotherapy. In the differential diagnosis, Raynaud's syndrome should be considered as a premonitory paraneoplasia, a risk factor for the occurrence of acral necrosis in patients with a malignant tumour undergoing chemotherapy, particularly patients with ovarian carcinoma receiving gemcitabine treatment.


Asunto(s)
Desoxicitidina/análogos & derivados , Dedos/patología , Dermatosis de la Mano/inducido químicamente , Dermatosis de la Mano/terapia , Neoplasias Ováricas/tratamiento farmacológico , Púrpura Trombocitopénica Trombótica/inducido químicamente , Púrpura Trombocitopénica Trombótica/terapia , Desoxicitidina/efectos adversos , Femenino , Humanos , Persona de Mediana Edad , Necrosis/inducido químicamente , Necrosis/terapia , Neoplasias Ováricas/complicaciones , Resultado del Tratamiento , Gemcitabina
3.
Int J Cosmet Sci ; 28(5): 343-7, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18489298

RESUMEN

The influence of androgens, especially testosterone and its effector dihydrotestosterone, results in a constitutive disadvantage for male skin, e.g. reduced viability of hair at the scalp and reduced epidermal permeability barrier repair capacity. Dihydrotestosterone can act, among others, as an adenyl cyclase inhibitor. Caffeine on the other hand is an inexpensive and (in regular doses) harmless substance used in various cosmetic products, which can act as a phosphodiesterase inhibitor. To prove the hypothesis that caffeine as a phosphodiesterase inhibitor is able to override testosterone-induced effects on barrier function, we performed a double-blind placebo controlled study with healthy volunteers. In this study, 0.5% caffeine in a hydroxyethylcellulose gel preparation (HEC) was applied on one forearm, HEC without caffeine on the other forearm of male and female volunteers for 7 days and transepidermal water loss (TEWL) was measured before and at the end of the treatment period. Basal TEWL did not differ significantly between male and female subjects but the application of caffeine significantly reduced TEWL in male skin compared with female skin. We conclude that caffeine is beneficial for barrier function in male skin.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA